Literature DB >> 3861752

Analysis of human monocyte chemoattractant binding by flow cytometry.

E J Leonard, K Noer, A Skeel.   

Abstract

The chemotactic peptide fMet-Leu-Phe-Lys is a potent chemoattractant for human blood monocytes. However, only one-third of the monocytes respond. To determine whether or not lack of response reflected absence of attractant receptors, we equilibrated peripheral blood mononuclear cells with fMet-Leu-Phe-Lys-FITC and analyzed binding by flow cytometry. The fluoresceinated peptide bound rapidly at 0 degree C, and the amount bound approached saturation with increasing concentration. The percentage of blood monocytes that bound the peptide was 60 +/- 8 (SEM for seven experiments). In contrast, only 36 +/- 3% (SEM for 16 experiments) of monocytes responded to the attractant by directed migration. It follows that, among the 64 nonmigrating monocytes per 100 total monocytes, approximately 40, or two-thirds of them, fail to bind attractant; the remaining one-third bind attractant but do not respond with directed movement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861752     DOI: 10.1002/jlb.38.3.403

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.

Authors:  A Rot; L E Henderson; T D Copeland; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Selective induction of phospholipase D1 in pathogen-activated human monocytes.

Authors:  M Locati; E Riboldi; R Bonecchi; P Transidico; S Bernasconi; B Haribabu; A J Morris; A Mantovani; S Sozzani
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

3.  Formylmethionyl-leucylphenylalanine and the SOS operon in Escherichia coli: a model of host-bacterial interactions.

Authors:  M F Broom; R M Sherriff; D M Ferry; V S Chadwick
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.